Medical News

RSS

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

The Special Committee of Independent Directors of Patheon Inc. (TSX:PTI) and Lonza Group AG (SIX:LONN) announced today that Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of US$3.55 per Restricted Voting Share.

21 Aug 2009

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

The Miss Universe contestants continued preparations for Sunday night's pageant by competing today in the Condom Olympics - tossing water-filled condoms to test their strength and playing "Wild Fire Infection" games that demonstrate the serious side of HIV infection.

21 Aug 2009

DTC Perspectives announces second annual class of inductees into the DTC Hall of Fame

DTC Perspectives Inc., the leading training, publishing, and analytics company for direct-to-consumer marketing, is proud to announce its second annual class of inductees into the DTC Hall of Fame.

21 Aug 2009

National Health Partners issues guidance for third-quarter 2009

National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company’s history that it has achieved positive cash flows from operating activities for a full month.

21 Aug 2009

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.

21 Aug 2009

URAC extends support to develop and standardize health care quality improvement measures

URAC, the nation's leading healthcare accreditation and education organization, announced today that it has joined the more than 180 organizations supporting Stand for Quality. Stand for Quality is made up of organizations including AARP, the American Medical Association, National Consumers League, and the U.S. Chamber of Commerce that represent every segment of the health care industry.

21 Aug 2009

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

...

21 Aug 2009

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

...

21 Aug 2009

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

Thursday's state news includes concerns over Medicaid reimbursement cuts in Colorado, the opening of the Utah Health Exchange amidst skyrocketing premiums and the high number of uninsured in Texas.

21 Aug 2009

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone.

21 Aug 2009

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

CEL-SCI Corporation. (NYSE Amex: CVM), a biotechnology company entering a late stage oncology trial and focused on infectious disease, today announced that it has entered into a definitive agreement with several institutional investors to sell 9.7 million units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $4.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.

21 Aug 2009

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.

21 Aug 2009

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

21 Aug 2009

Interfix receives AHDI Integrity Award for Innovation Through Technology

InterFix LLC is the 2009 recipient of the AHDI Integrity Award for Innovation Through Technology for the release of its BenchMark KB™ Knowledge Base product in 2008. The Integrity Awards focus on contributions made by individuals and corporations that align with the Association’s focus on integrity. The awards are designed to highlight innovative thinking and best practices that the Association believes will drive the clinical documentation sector in the coming years.

21 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, from Eli Lilly Canada Inc. Takeda, the discoverer of ACTOS, licensed the drug to Lilly as part of a worldwide agreement in 1999.

21 Aug 2009

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

More than 1 million Kenyans living in prolonged drought conditions are not getting the food aid they need, Gabrielle Menezes, a spokeswoman for the U.N.'s World Food Program (WFP), said recently, the Associated Press reports. She said WFP already provides emergency food aid to about 2.5 million people in Kenya, but another 1.3 million still need help.

21 Aug 2009

Sound Inpatient Physicians and Obama discuss on health care reform

Brett Kronenberger, M.D., a Chief Hospitalist of Sound Inpatient Physicians, and a group of community leaders held a private meeting with President Barack Obama prior to the Town Hall meeting on health care reform, in Belgrade, Montana last Friday.

21 Aug 2009

Synthes to distribute ECM products manufactured by Kensey Nash following a strategic agreement

Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.

21 Aug 2009

Syntagon to deliver presentation on controlling genotoxic impurities

Leading contract research organisation, Syntagon, is to deliver a presentation on controlling genotoxic impurities at one of the Pharma industry’s highest profile events, CPhI Worldwide, being held this October in Madrid, Spain.

21 Aug 2009

Medical News

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

DTC Perspectives announces second annual class of inductees into the DTC Hall of Fame

National Health Partners issues guidance for third-quarter 2009

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

URAC extends support to develop and standardize health care quality improvement measures

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Interfix receives AHDI Integrity Award for Innovation Through Technology

Cannabis chemicals stop prostate cancer growth

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

Sound Inpatient Physicians and Obama discuss on health care reform

Synthes to distribute ECM products manufactured by Kensey Nash following a strategic agreement

Syntagon to deliver presentation on controlling genotoxic impurities

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News